The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 12, 2021

Filed:

Nov. 06, 2017
Applicants:

Washington University, Saint Louis, MO (US);

Multiple Myeloma Research Foundation, Norwalk, CT (US);

Inventors:

Brian White, Seattle, WA (US);

Irena Lanc, St. Louis, MO (US);

Robert Fulton, Worden, IL (US);

Daniel Auclair, Middletown, CT (US);

Michael H. Tomasson, Coralville, IA (US);

Assignee:

Washington University, St. Louis, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01J 19/00 (2006.01); C40B 40/06 (2006.01); C12Q 1/686 (2018.01); C12P 19/34 (2006.01); C12Q 1/6886 (2018.01); C12Q 1/6827 (2018.01); G16B 20/10 (2019.01); G16B 30/10 (2019.01); G16B 20/40 (2019.01); G16B 20/20 (2019.01); G16B 30/00 (2019.01); G16B 20/00 (2019.01);
U.S. Cl.
CPC ...
B01J 19/0046 (2013.01); C12P 19/34 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6886 (2013.01); C40B 40/06 (2013.01); G16B 20/10 (2019.02); G16B 20/20 (2019.02); G16B 20/40 (2019.02); G16B 30/10 (2019.02); B01J 2219/00387 (2013.01); B01J 2219/00722 (2013.01); C12Q 2600/156 (2013.01); G16B 20/00 (2019.02); G16B 30/00 (2019.02);
Abstract

A sequencing capture array for identifying mutations in Multiple Myeloma is disclosed. Also disclosed are targeted next generation sequencing methods for identifying SNV, CNV, and translocation mutations in Multiple Myeloma tumor cells. A capture array representing fewer than 500 genes implicated in Multiple Myeloma can be used to analyze tumor mutations and create a personalized treatment plan for a Multiple Myeloma patient. Analytical methods are presented that allow tumor mutations to be elucidated with coverage at a sequencing depth of no more than 500×, or as low as 100×, with optimal efficiency achieved at a sequencing depth of about 300×.


Find Patent Forward Citations

Quick Actions:

White, Brian. (2021). Automated exposition of known and novel multiple myeloma genomic variants using a single sequencing platform (U.S. Patent No. 11141709). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11141709

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…